Business article - February 10, 2017
Crowdfunding turns public interest into a cash boost
The funding model connects startup companies with investors and basic researchers with backers, reports Chris Tachibana. In 2012, the AssiStep, a handrail for people who need help with stairs, was just a clever student project. Last year, it hit the market. Norwegian University of Science and Technology graduates Halvor Wold, Ingrid Lonar, and Eirik Gjelsvik […]
Financing - February 9, 2017
Oncoinvent closes $25 million private placement
Norwegian company Oncoinvent has announced the closing of a 210 MNOK (approx. 25 MUSD) private placement of ordinary shares. Large privately owned investment companies joining the company as new investors include Geveran Trading Co. Ltd., Canica AS, CGS Holding AS, Helene Sundt AS and Must Invest AS. Oncoinvent AS is developing therapeutics to combat various […]
Financing - January 16, 2017
2A Pharma raises SEK 27 million
The Swedish/Danish biotech company 2A Pharma has closed its first financing round and has been granted an exclusive, worldwide license from Medigene for its adeno-associated virus like particles (AAVLPs) technology. 2A Pharma AB, based in Malmö, Sweden with research facilities in Aalborg, Denmark, aims to develop novel, cost effective vaccines and therapeutics based on Medigene […]
Financing - January 4, 2017
Antaros Medical and Almi Invest adds 3 MSEK to Emeriti Pharma
Emeriti Pharma, which is developing a new treatment for skin diseases, takes up two million in venture capital from Antaros Medical. The existing owner, Almi Invest, is also participating in the funding, which has a total value of three million SEK. Emeriti Pharma also announces that the company is currently conducting a Phase 1 study […]
Biotech Business - December 20, 2016
Betagenon receives EUR 1.8 million
The Umeå based company Betagenon receives €1,8 million, from EU’s sought after Horizon 2020 program, to close the gap to the market for their drug against obesity induced diabetes and associated cardiovascular disease. “An increase in calorie intake combined with an inactive life style has brought about a global epidemic of obesity, fatty liver and […]
Financing - December 13, 2016
Nordic Nanovector raised 500 MNOK
Nordic Nanovector has raised MNOK 500 in gross proceeds through a private placement of 4,374,244 new shares. Nordic Nanovector intends to use the net proceeds to fund a Phase 2 combination study of Betalutin® and Rituximab CD20, fund a Phase 1 study and GMP manufacturing for 177Lu-conjugated chimeric antibody (anti-CD37 ARC), develop new proprietary antibody […]
